HCPCS code A9575: Gadoterate injection, per 0.1 mL2026 Medicare rate & RVUs in Louisiana

Reports gadoterate meglumine administered as intravenous MRI contrast, with each HCPCS unit representing 0.1 mL of drug.

CMS RVU26DEffective Oct 1, 20262 payment localities

CMS doesn’t publish an office rate for A9575 in Louisiana.

—Office (non-facility)
—Hospital or facility

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

Your location

Medicare pays by the payment locality where the service is performed.

On this page 9 sections
  1. Rate in Louisiana
  2. What A9575 covers
  3. By payment locality
  4. How it’s calculated
  5. Payment rules
  6. Similar codes
  7. Related codes
  8. Billing questions
  9. Sources

What A9575 covers

Gadoterate meglumine is an intravenous gadolinium-based contrast agent used during MRI to enhance visualization. Hospital imaging departments, outpatient MRI centers, and other facilities administering contrast may report the drug when it is supplied and administered for the study. The code identifies the contrast agent and its quantity, not the MRI acquisition or interpretation.

Medicare assigns this code status X: it is not a physician service under the Medicare statute, so the physician fee schedule does not pay it. When covered, payment is under another fee schedule or payment system; HCPCS pricing assigns other-contractor pricing, with the Medicare contractor setting payment. Coverage is left to the Medicare contractor’s judgment. Each unit represents 0.1 mL of gadoterate meglumine, so units are based on the volume reported.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where A9575 pays more and less in Louisiana

A9575 office and facility rates by payment locality
Payment localityOfficeFacility
New Orleans, LAUnavailableUnavailable
Rest of LouisianaUnavailableUnavailable

How the A9575 rate is calculated

Each of A9575’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

How the rate is built · A9575

RVUs × geographic indexes × conversion factor

Office or facility?

Work0.00

0.00 RVUs× 1.000 GPCI

Practice expense0.00

0.00 RVUs× 1.000 GPCI

Malpractice0.00

0.00 RVUs× 1.000 GPCI

Adjusted RVUs

0.0000

Conversion factor

$33.4009

Medicare rate

$0.00

Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.

Payment rules and modifiers for A9575

A9575 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

Place of service · A9575

Which rate does Medicare pay?

The POS code on the claim line (CMS-1500 box 24B).

POS 11 · non-facility rate · national

—

A9575 isn’t priced in this setting.

A9575 compared with similar codes

Compare codes · National

5 codes, side by side

Office or facility?

  • A9575

    Gadoterate injection, per 0.1 mL0 wRVU

    Not priced

  • A9579

    MRI contrast agent, unspecified agent, per mL0 wRVU

    Not priced

  • A9573

    Gadopiclenol injection, per 1 mL0 wRVU

    Not priced

  • A9585

    Gadobutrol injection, per 0.1 mL0 wRVU

    Not priced

  • A9576

    ProHance injection, per 1 mL0 wRVU

    Not priced

How to choose

A9579MRI contrast agentUnspecified agent, per mL
A9575 identifies gadoterate meglumine; A9579 is for gadolinium-based MRI contrast when the agent is reported under the nonspecific code.
A9573Gadopiclenol injectionPer 1 mL
A9573 identifies gadopiclenol. Use A9575 when the administered contrast agent is gadoterate meglumine.
A9585Gadobutrol injectionPer 0.1 mL
A9585 identifies gadobutrol, not gadoterate meglumine. Select the code matching the agent administered.
A9576ProHance injectionPer 1 mL
A9576 identifies ProHance multipack; A9575 identifies gadoterate meglumine.

A9575 billing questions

How many milliliters does one unit represent?

One unit represents 0.1 mL of gadoterate meglumine. Report units based on the volume represented by the drug claim.

Does A9575 include the MRI or its interpretation?

No. A9575 identifies the gadoterate contrast agent and its quantity, not the MRI acquisition or interpretation.

Does Medicare pay A9575 under the physician fee schedule?

No. Status X identifies it as a statutory exclusion from physician fee schedule payment; when covered, it is handled under another fee schedule or payment system.

Who determines whether Medicare covers this code?

Coverage is left to the Medicare contractor’s judgment. The contractor also sets payment under the HCPCS other-contractor pricing method.

When should a different gadolinium contrast code be selected?

Use a different code when the administered agent is a different named product or when the agent is reported under the applicable nonspecific contrast code. A9575 identifies gadoterate meglumine.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates

Did this answer your question about what A9575 pays in Louisiana?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put A9575 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist